“Emerging evidence reports saliva sampling is sensitive than nasopharyngeal swabs”
BioSpectrum Asia|August 2020
“Emerging evidence reports saliva sampling is sensitive than nasopharyngeal swabs”
The use of saliva to test for COVID-19 is being considered an important step by the health authorities as Singapore ramps up its testing capacity. Molecular diagnostic startup Lucence is supporting this initiative with its newly developed saliva testing kit. BioSpectrum Asia reached out to Dr. Tan Min-Han, Chief Executive Officer and Medical Director, Lucence, Singapore to find out more about the company’s contributions. Edited excerpts;
Dr Manbeena Chawla

Dr Tan Min-Han, Chief Executive Officer and Medical Director, Lucence, Singapore

What are the major initiatives being taken by Lucence in this fight against COVID-19?

articleRead

You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber

GoldLogo

Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines

READ THE ENTIRE ISSUE

August 2020